# Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children

> **NCT00144430** · PHASE2 · COMPLETED · sponsor: **Ann & Robert H Lurie Children's Hospital of Chicago** · enrollment: 60 (estimated)

## Conditions studied

- Graft vs Host Disease

## Interventions

- **DRUG:** Pentostatin

## Key facts

- **NCT ID:** NCT00144430
- **Lead sponsor:** Ann & Robert H Lurie Children's Hospital of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144430, "Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00144430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*